| # | Drug | Count |
|---|---|---|
| 0 | CLOZAPINE | 1641 |
| 1 | QUETIAPINE | 278 |
| 2 | LITHIUM CARBONATE | 246 |
| 3 | LITHIUM | 245 |
| 4 | LITHIUM BROMATUM | 245 |
| 5 | OLANZAPINE | 244 |
| 6 | ARIPIPRAZOLE | 240 |
| 7 | ARIPIPRAZOLE ORAL | 183 |
| 8 | ARIPIPRAZOLE ORALLY DISINTEGRATING | 183 |
| 9 | FLUOXETINE HYDROCHLORIDE | 169 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMISULPRIDE | 139 | 0.0227 |
| 1 | LITHIUM CARBONATE | 246 | 0.0144 |
| 2 | CLOZAPINE | 1641 | 0.0130 |
| 3 | DISULFIRAM | 11 | 0.0097 |
| 4 | LITHIUM | 245 | 0.0096 |
| 5 | CHLORPROMAZINE HYDROCHLORIDE | 8 | 0.0084 |
| 6 | ZIPRASIDONE | 25 | 0.0069 |
| 7 | HALOPERIDOL DECANOATE | 12 | 0.0069 |
| 8 | FLUVOXAMINE MALEATE | 16 | 0.0066 |
| 9 | VALPROATE SODIUM | 125 | 0.0059 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 2021 |
| 1 | Benzodiazepine [EPC] | 454 |
| 2 | Mood Stabilizer [EPC] | 263 |
| 3 | Anti-epileptic Agent [EPC] | 251 |
| 4 | Proton Pump Inhibitor [EPC] | 177 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 146 |
| 6 | Dopamine-2 Receptor Antagonist [EPC] | 139 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 102 |
| 8 | Typical Antipsychotic [EPC] | 93 |
| 9 | Osmotic Laxative [EPC] | 92 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Dopamine-2 Receptor Antagonist [EPC] | 139 | 0.0178 |
| 1 | Aldehyde Dehydrogenase Inhibitor [EPC] | 11 | 0.0097 |
| 2 | Atypical Antipsychotic [EPC] | 2021 | 0.0045 |
| 3 | Typical Antipsychotic [EPC] | 93 | 0.0037 |
| 4 | Anticholinergic [EPC] | 31 | 0.0019 |
| 5 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 6 | Mood Stabilizer [EPC] | 263 | 0.0012 |
| 7 | Anti-epileptic Agent [EPC] | 251 | 0.0011 |
| 8 | Cholinergic Muscarinic Antagonist [EPC] | 33 | 0.0008 |
| 9 | Provitamin D2 Compound [EPC] | 25 | 0.0008 |